Assigning stability to Zerbaxa (ceftolozane/tazobactam) in elastomeric infusers
16 November 2022Assessment of the degradation profile and toxicity data for Zerbaxa is available for its use in Outpatient Parenteral Antimicrobial Therapy (OPAT) services
ZerbaxaMerck Sharp & Dohme Limited
Merck Sharp & Dohme Limited
Concentrate for solution for infusion, 1g/0.5g
Contact MSD in all cases where a deviation from the recommended storage conditions has occurred. Refer to the electronic medicines compendium (eMC) at https://www.medicines.org.uk for company contact details.
21 February 2022
London MI Service